Ryan E. Michael
8Patents
4h-index
15Co-inventors
46Inventor score
Filing activity: Nov 9, 2018 → May 8, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10660968B2 | Spirocyclic degronimers for target protein degradation | Emerging Cross-Sectional Technologies | 23 | Active |
| US10646575B2 | Heterocyclic degronimers for target protein degradation | Chemistry; Metallurgy | 22 | Active |
| US10905768B1 | Heterocyclic degronimers for target protein degradation | Chemistry; Metallurgy | 21 | Active |
| US11185592B2 | Spirocyclic degronimers for target protein degradation | Emerging Cross-Sectional Technologies | 14 | Active |
| US11673902B2 | Isoindolinone and indazole compounds for the degradation of EGFR | Chemistry; Metallurgy | 1 | Active |
| US12371442B2 | Isoindolinone and indazole compounds for the degradation of EGFR | Chemistry; Metallurgy | 0 | Active |
| US12076405B2 | Heterocyclic degronimers for target protein degradation | Chemistry; Metallurgy | 0 | Active |
| US12048748B2 | Spirocyclic degronimers for target protein degradation | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.